These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22167063)

  • 1. Geographic variation in implantable cardioverter-defibrillator use and heart failure survival.
    Epstein AJ; Polsky D; Yang F; Yang L; Groeneveld PW
    Med Care; 2012 Jan; 50(1):10-7. PubMed ID: 22167063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Marzec LN; Peterson PN; Bao H; Curtis JP; Masoudi FA; Varosy PD; Bradley SM
    JAMA Cardiol; 2017 May; 2(5):561-565. PubMed ID: 28122073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
    Friedman DJ; Singh JP; Curtis JP; Tang WHW; Bao H; Spatz ES; Hernandez AF; Patel UD; Al-Khatib SM
    J Am Coll Cardiol; 2015 Dec; 66(23):2618-2629. PubMed ID: 26670062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
    Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
    JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.
    Ziaeian B; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    J Am Coll Cardiol; 2014 Aug; 64(8):797-807. PubMed ID: 25145524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications and Mortality Following CRT-D Versus ICD Implants in Older Medicare Beneficiaries With Heart Failure.
    Zeitler EP; Austin AM; Leggett CG; Gilstrap LG; Friedman DJ; Skinner JS; Al-Khatib SM
    JACC Heart Fail; 2022 Mar; 10(3):147-157. PubMed ID: 35241242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Device Histogram-Based Simple Predictor of Mortality Risk in ICD and CRT-D Patients: The Heart Rate Score.
    Wilkoff BL; Richards M; Sharma A; Wold N; Jones P; Perschbacher D; Olshansky B
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):333-343. PubMed ID: 28156008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Implementation of QRS Characteristics in the Seattle Heart Failure Model in ICD and CRT-D Recipients.
    VAN DER Heijden AC; Levy WC; VAN Erven L; Schalij MJ; Borleffs CJ
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):565-73. PubMed ID: 27027982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to the Center for Medicare & Medicaid Services coverage with evidence development request for primary prevention implantable cardioverter-defibrillators: data from the OMNI study.
    Sweeney MO; Sakaguchi S; Simons G; Machado C; Connett JE; Yang F;
    Heart Rhythm; 2012 Jul; 9(7):1058-66. PubMed ID: 22387371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.
    Al-Khatib SM; Hellkamp AS; Fonarow GC; Mark DB; Curtis LH; Hernandez AF; Anstrom KJ; Peterson ED; Sanders GD; Al-Khalidi HR; Hammill BG; Heidenreich PA; Hammill SC
    JAMA; 2014 Jun; 311(21):2209-15. PubMed ID: 24893088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.
    Pun PH; Sheng S; Sanders G; DeVore AD; Friedman D; Fonarow GC; Heidenreich PA; Yancy CW; Hernandez AF; Al-Khatib SM
    Am J Cardiol; 2017 Mar; 119(6):886-892. PubMed ID: 28160975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
    Kramer DB; Normand ST; Volya R; Hatfield LA
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.